| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 37.7 | 37.8 | 29.1 |
| Other income | 1.6 | 0.9 | 1.1 |
| Total income | 39.3 | 38.6 | 30.2 |
| Profit before exceptional items & tax | 0.6 | -1.1 | 0.2 |
| Profit before tax | 0.6 | -1.1 | 0.2 |
| Net profit | 0.5 | 1.0 | 0.2 |
| Operating margin | 1.5% | -2.8% | 0.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +150.00% |
|---|---|
| Net profit, quarter on quarter | -50.00% |
| Revenue, year on year | +29.60% |
| Operating profit, year on year | -11.10% |
| Operating profit, quarter on quarter | +50.00% |
BSE results filing, NSE: INDRANIB. Figures extracted from the filing.
Indrayani Biotech Ltd: key numbers
- Share price
- ₹8.25
- Market cap
- ₹44.28 Cr
- Revenue (annual)
- ₹137.8 Cr
- Net profit (annual)
- ₹2.16 Cr
- P/E (TTM)
- 21.1×Sector 26.8×
- Promoter holding
- 32.92%-0.34% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indrayani Biotech Ltd
All →Indrayani Biotech Legal & Regulatory
Indrayani Biotech received a tax recovery notice for outstanding demands totaling ₹1.17 Crore for various assessment years, for which the company has filed responses.
- Value
- ₹1.17 Cr
Indrayani Biotech Management Change
Independent Director Mr. K.S. Vaidyanathan has resigned from the Board of Indrayani Biotech Limited, effective October 13, 2026, due to personal reasons.
Indrayani Biotech Other Announcement
Indrayani Biotech Limited submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Indrayani Biotech Merger & Restructuring
Indrayani Biotech sold shares of its subsidiary, Dindigul Farm Product Limited, to the open market. This divestment marks a reduction in the company's subsidiary holding.
Indrayani Biotech Board Meeting Date
Indrayani Biotech will hold a board meeting on October 7, 2026, to consider the company's unaudited financial results for the quarter ended June 30, 2026.
Indrayani Biotech Capital Structure Change
Indrayani Biotech announced its Rights Issue of up to 3.25 crore partly paid-up equity shares at ₹15 per share, aggregating to ₹48.79 Crore.
- Value
- ₹48.79 Cr